The latest report by IMARC Group, titled “Immunohematology Market Report by Product (Analyzing Systems, Reagents and Consumables), Technology (Biochips, Gel Cards, Microplates, Polymerase Chain Reaction, Erythrocyte-Magnetized Technology (EMT), and Others), Application (Blood-Related Diseases, HIV, Hepatitis, Blood Transfusion, and Others), End-User (Hospitals, Blood Banks, Diagnostic Laboratories, and Others), and Region 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on the market.
How big is the immunohematology market?
The global immunohematology market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.2% during 2024-2032.
Leading Companies in the Immunohematology Industry:
- Abbott
- Antisel
- BD (Becton Dickinson and Company)
- Beckman Coulter Inc. (Danaher Corporation)
- Bio-Rad Laboratories Inc.
- Hoffmann-La Roche Ltd.
- Grifols S.A.
- Merck KGaA
- MTC Invitro Diagnostics AG
- Ortho-Clinical Diagnostics Inc (The Carlyle Group)
- Siemens Healthcare GmbH
- Thermo Fisher Scientific Inc
Factors Affecting the Growth of the Immunohematology Industry:
- Increasing Demand for Blood Transfusions:
The growing need for blood transfusions, driven by a rising number of surgical procedures, trauma cases, and cancer treatments, significantly impacts the immunohematology market. Blood transfusions are vital for various medical conditions and surgeries, requiring precise crossmatching and blood typing to avoid adverse reactions. As the global population ages and the incidence of medical conditions requiring transfusions increases, the demand for immunohematology testing products and services escalates. This is further supported by improvements in healthcare infrastructure and the availability of advanced healthcare services in emerging economies, where the need for efficient and safe blood transfusion processes is becoming increasingly critical. This demand is propelling investments in immunohematology research and development, leading to market growth.
- Rising Prevalence of Hematological Diseases:
The global increase in hematological diseases such as anemia, leukemia, and hemophilia is a significant driver of the immunohematology market. These conditions require precise blood typing and antibody screening to ensure compatibility and safety in blood transfusions, which are critical components of treatment. As the incidence of these diseases rises, the demand for immunohematology testing also increases to prevent transfusion-related complications. This rising prevalence is pushing healthcare systems worldwide to invest in immunohematology products and services, driving market growth. Furthermore, the growing awareness and better screening programs for blood-related disorders contribute to the early diagnosis and treatment, further fueling the demand for immunohematology diagnostics and therapeutics.
- Technological Advancements:
The immunohematology market is experiencing significant growth driven by advancements in technology and automation. These innovations have led to the development of sophisticated testing platforms that offer faster, more accurate, and reliable blood testing results. Automated systems reduce manual errors, increase throughput, and ensure consistent results, which are crucial for diagnosing and treating various blood disorders efficiently. Moreover, the integration of IT solutions and AI in immunohematology devices enhances data management and interpretation, enabling personalized patient care and management. As healthcare providers increasingly adopt these advanced technologies to meet the growing demand for safe blood transfusion services and blood disorder screenings, the market for immunohematology continues to expand.
For an in-depth analysis, you can request a sample copy of the report: https://www.imarcgroup.com/immunohematology-market/requestsample
Global Immunohematology Market Trends:
The immunohematology market is witnessing continuous technological advancements aimed at improving testing efficiency, accuracy, and automation. Innovations in blood typing methods, antibody screening techniques, and molecular testing technologies are enhancing the capabilities of immunohematology assays. Automated platforms, multiplex testing systems, and point-of-care devices are gaining traction for blood compatibility testing and infectious disease screening, enabling faster turnaround times and streamlining workflow processes in blood banks and clinical laboratories. Besides, there is an increasing emphasis on blood safety and transfusion medicine practices worldwide, driving the demand for immunohematology solutions. Blood transfusions are essential medical procedures for patients undergoing surgery, trauma care, cancer treatment, and organ transplantation.
Immunohematology Market Report Segmentation:
By Product:
- Analyzing Systems
- Reagents and Consumables
Reagents and consumables represent the leading segment as they are essential components in immunohematology testing procedures.
By Technology:
- Biochips
- Gel Cards
- Microplates
- Polymerase Chain Reaction
- Erythrocyte-Magnetized Technology (EMT)
- Others
Polymerase chain reaction (PCR) technology accounts for the largest market share as it plays a crucial role in immunohematology, particularly in blood screening and infectious disease testing, including HIV.
By Application:
- Blood-Related Diseases
- HIV
- Hepatitis
- Blood Transfusion
- Others
HIV testing holds the largest market share as HIV screening and detection are critical components of blood transfusion safety protocols to prevent the transmission of HIV through contaminated blood products.
By End User:
- Hospitals
- Blood Banks
- Diagnostic Laboratories
- Others
Hospitals dominate the market as they serve as major end users of immunohematology products and services, including blood banking, transfusion medicine, and infectious disease testing.
By Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America’s dominance in the immunohematology market is attributed to advanced healthcare infrastructure, high healthcare spending, and stringent regulatory standards for blood banking and transfusion medicine practices.
Ask the Analyst for Customization https://www.imarcgroup.com/request?type=report&id=2256&flag=C
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
